Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Free Cash Flow (2016 - 2017)

Bone Biologics (BBLG) has disclosed Free Cash Flow for 2 consecutive years, with -$931700.0 as the latest value for Q4 2017.

  • On a quarterly basis, Free Cash Flow rose 26.51% to -$931700.0 in Q4 2017 year-over-year; TTM through Dec 2017 was -$3.3 million, a 54.56% increase, with the full-year FY2025 number at -$2.7 million, up 34.76% from a year prior.
  • Free Cash Flow was -$931700.0 for Q4 2017 at Bone Biologics, down from -$561035.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$561035.0 in Q3 2017 to a low of -$2.5 million in Q1 2016.